Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06883513

Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID

Led by University of Louisville · Updated on 2025-03-19

20

Participants Needed

1

Research Sites

9 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is investigating the effects of using an Osteopathic Manipulative Therapy (OMT) treatment protocol that was shown to statistically improve smell in individuals suffering from Long-COVID olfactory (smell) dysfunction in a small single-blinded pilot trial conducted during 2021. The questions this study is trying to answer are: 1. Does this OMT protocol improve other non-smell related Long-COVID symptoms 2. Do 2 OMT treatments improve Long-COVID symptoms more than 1 OMT treatment Participants will: 1. Week 1: Take an digital survey regarding their Long-COVID symptoms undergo Long-COVID OMT treatment or a placebo treatment 2. Week 2: Take an digital survey regarding their Long-COVID symptoms then all will undergo Long-COVID OMT treatment 3. Week 3: Take an digital survey regarding their Long-COVID symptoms 4. Week 8: Take an digital survey regarding their Long-COVID symptoms

CONDITIONS

Official Title

Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals must have had a positive SARS-CoV-2 test at least 6 weeks before consenting
  • Individuals must have at least one Long-COVID symptom lasting more than 6 weeks that affects daily life, including but not limited to: shortness of breath, difficulty with movement, muscle pain or stiffness, changes in sexual desire, generalized pain, sleep difficulties, mood changes, erectile function changes (males only), palpitations, altered taste or smell, hair changes, urination changes, dizziness, skin changes, bowel changes, fatigue, indigestion, dry or irritated eyes, sweating changes, memory or thinking difficulties, stomach pain, menstrual changes (females only), chills or shivering
Not Eligible

You will not qualify if you...

  • Denial of any above listed Long-COVID symptoms before consent
  • Fractured bones within the last 3 months
  • Current participation in other Long-COVID trials involving interventions during this study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Louisville Outpatient Care Center

Louisville, Kentucky, United States, 40202

Actively Recruiting

Loading map...

Research Team

M

Michael E Stenta, DO, Doctor of Osteopathic Medicine

CONTACT

R

Rebecca Lynn, DO, Doctor of Osteopathic Medicine

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here